These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34549521)

  • 1. A note on confidence intervals for the restricted mean survival time based on transformations in small sample size.
    Hashimoto H; Kada A
    Pharm Stat; 2022 Mar; 21(2):309-316. PubMed ID: 34549521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some new confidence intervals for Kaplan-Meier based estimators from one and two sample survival data.
    Tang Y
    Stat Med; 2021 Oct; 40(23):4961-4976. PubMed ID: 34131948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Five methods for the estimation of confidence intervals on survival rate].
    Xiang YB; Gao YT; Jin F
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):306-9. PubMed ID: 8706102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size calculations for single-arm survival studies using transformations of the Kaplan-Meier estimator.
    Nagashima K; Noma H; Sato Y; Gosho M
    Pharm Stat; 2021 May; 20(3):499-511. PubMed ID: 33347712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approximate confidence intervals for probabilities of survival and quantiles in life-table analysis.
    Anderson JR; Bernstein L; Pike MC
    Biometrics; 1982 Jun; 38(2):407-16. PubMed ID: 7115871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of median survival time and its 95% confidence interval using SAS PROC LIFETEST.
    Talsma PA
    J Biopharm Stat; 2024 May; 34(3):366-378. PubMed ID: 37144552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of limited sample size and follow-up on single event survival extrapolation for health technology assessment: a simulation study.
    Beca JM; Chan KKW; Naimark DMJ; Pechlivanoglou P
    BMC Med Res Methodol; 2021 Dec; 21(1):282. PubMed ID: 34922454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic RMST curves for survival analysis in clinical trials.
    Liao JJZ; Liu GF; Wu WC
    BMC Med Res Methodol; 2020 Aug; 20(1):218. PubMed ID: 32854619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confidence intervals for the Mann-Whitney test.
    Perme MP; Manevski D
    Stat Methods Med Res; 2019 Dec; 28(12):3755-3768. PubMed ID: 30514179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On permutation tests for comparing restricted mean survival time with small sample from randomized trials.
    Horiguchi M; Uno H
    Stat Med; 2020 Sep; 39(20):2655-2670. PubMed ID: 32432805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data.
    Choudhury JB
    Stat Med; 2002 Apr; 21(8):1129-44. PubMed ID: 11933038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restricted mean survival time as a summary measure of time-to-event outcome.
    Hasegawa T; Misawa S; Nakagawa S; Tanaka S; Tanase T; Ugai H; Wakana A; Yodo Y; Tsuchiya S; Suganami H;
    Pharm Stat; 2020 Jul; 19(4):436-453. PubMed ID: 32072769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of proportional data in reproductive and developmental toxicity studies: Comparison of sensitivities of logit transformation, arcsine square root transformation, and nonparametric analysis.
    Feder PI; Aume LL; Triplett CA; Simmons JE; Narotsky MG
    Birth Defects Res; 2020 Oct; 112(16):1260-1272. PubMed ID: 32735073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time-to-event end point.
    Huang B; Kuan PF
    Pharm Stat; 2018 May; 17(3):202-213. PubMed ID: 29282880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjusting for covariates in analysis based on restricted mean survival times.
    Zhong Y; Zhao O; Zhang B; Yao B
    Pharm Stat; 2022 Jan; 21(1):38-54. PubMed ID: 34231308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group.
    Everest L; Blommaert S; Tu D; Pater JL; Hay A; Cheung MC; Chan KKW
    Value Health; 2022 Jul; 25(7):1157-1164. PubMed ID: 35779942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nonparametric approach to confidence intervals for concordance index and difference between correlated indices.
    Zou G; Smith E; Jairath V
    J Biopharm Stat; 2022 Sep; 32(5):740-767. PubMed ID: 35216545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On logit confidence intervals for the odds ratio with small samples.
    Agresti A
    Biometrics; 1999 Jun; 55(2):597-602. PubMed ID: 11318220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the means and variances of a bivariate log-normal distribution.
    Bebu I; Mathew T
    Stat Med; 2008 Jun; 27(14):2684-96. PubMed ID: 17907261
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.